Janssen and MeiraGTx Link on Optical Gene Therapy

06.02.2019 - Janssen, the pharmaceuticals arm of Johnson & Johnson, is once again collaborating with US clinical-stage gene therapy company MeiraGTx to develop and commercialize treatments for...